<div id="readability-page-1"><div> <div> Federal Policy Signals Accelerating GLP-1 Adoption — Menu-Order-AI Translates Clinical Access into Everyday Dining Decisions , /PRNewswire/ -- The Centers for Medicare &amp; Medicaid Services (CMS) has announced the BALANCE Model, a voluntary initiative designed to expand access to GLP-1 medications under Medicare and Medicaid through negotiated pricing and structured coverage. GLP-1 treatment is now embedded in federal healthcare policy. As access expands, consumer behavior shifts. Clinical guidance for GLP-1 patients emphasizes protein prioritization, portion control, and structured nutrition support to improve long-term outcomes. Yet millions of Americans still face a daily challenge: how to apply that guidance in real-world restaurant settings. Menu-Order-AI was built to solve that gap. The platform instantly analyzes any restaurant menu and highlights: • High-protein • GLP-1 friendly options — helping users translate metabolic goals into practical dining decisions from one restaurant choice or scan of a menu. The company recently surpassed 50,000 downloads and is trusted by over 20,000 users across 25+ countries, reflecting accelerating global demand for protein-prioritized, GLP-1 aligned dining tools. Global adoption continues to scale following the company's integration of Google Places technology. The integration strengthens Menu-Order-AI's global infrastructure, ensuring precise restaurant identification and scalable international coverage — capabilities legacy directory solutions were unable to consistently deliver at scale. &#34;The expansion of GLP-1 access at the federal level confirms this is not a trend — it's a structural shift in how Americans approach food and metabolic health. Prescriptions don't make choices at restaurants — people do. Menu-Order-AI turns clinical access into real-world, high-protein, GLP-1 friendly decisions from one restaurant choice or scan of a menu,&#34; says Melissa Butler, Founder of Menu-Order-AI. As national GLP-1 adoption accelerates, the demand for real-time behavioral support tools is expected to grow across healthcare, hospitality, and technology sectors. GLP-1 access is scaling nationally. The infrastructure supporting everyday decision-making must scale with it. About Menu-Order-AI Menu-Order-AI is the GLP-1 dining companion, instantly analyzing restaurant menus to surface high-protein, GLP-1 friendly options that align with metabolic health goals. Website https://www.menuorderai.com/ App Store https://apps.apple.com/us/app/menu-order-ai-find-glp1-meals/id6753690910 Google play store https://play.google.com/store/apps/details?id=co.menu.order&amp;pcampaignid=web_share Melissa Butler Founder Menu-Order AI [email protected] This release was issued through WebWire®. For more information, visit http://www.webwire.com. SOURCE MENU - ORDER AI <img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMzAzJk5ld3NJdGVtSWQ9Q0wwMDYwNyZUcmFuc21pc3Npb25fSWQ9MjAyNjAzMDMxNDMyUFJfTkVXU19VU1BSX19fX19DTDAwNjA3?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMzAzJk5ld3NJdGVtSWQ9Q0wwMDYwNyZUcmFuc21pc3Npb25fSWQ9MjAyNjAzMDMxNDMyUFJfTkVXU19VU1BSX19fX19DTDAwNjA3"/></div> </div></div>

The Centers for Medicare & Medicaid Services (CMS) has launched the BALANCE Model to expand access to GLP-1 medications under Medicare and Medicaid. This initiative aims to improve consumer behavior regarding dietary choices by integrating clinical guidance into everyday dining through the Menu-Order-AI platform. The app helps users find high-protein, GLP-1 friendly options at restaurants, reflecting a growing demand for tools that support metabolic health. As GLP-1 adoption increases, the need for real-time decision-making support in healthcare and hospitality is expected to rise.

prnewswire

SPDR S&P Biotech

First Trust NYSE Arca Biotech Index Fd

iShares US Pharma

Defiance Daily Target 2X Long LLY ETF

Direxion Daily LLY Bull 2X Shares

Invesco Biotechnology & Genome ETF

Invesco Nasdaq Biotechnology ETF

Novo Nordisk AS

iShares Global Healthcare

Ark Genomic Revolution ETF

Proshares Ultra Nasdaq Biotech

iShares US Medical Devices

ALPS Medical Breakthrough

VanEck Biotech ETF

Defiance Daily Target 2X Long NVO ETF

iShares Biotechnology ETF

Eli Lilly

VG Health

SPDR S&P Health Equip

14:32 ETGovernment Expands GLP-1 Access -- Menu-Order-AI Powers Everyday Decision Support